A noninvasive gene expression assay for cutaneous basal cell and squamous cell carcinoma

Background: A robust qRT-PCR-based noninvasive gene expression test that differentiates primary melanomas from similar looking benign pigmented lesions became available to dermatologists in the U.S. recently. Patient and clinician demand for a similar test to noninvasively differentiate nonmelanoma skin cancers (generally excised) from benign or precursor lesions (generally treated via nonsurgical modalities such as cryotherapy or chemical and immunologic destruction) has been growing.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research